ES2181908T3 - Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide. - Google Patents

Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.

Info

Publication number
ES2181908T3
ES2181908T3 ES96931100T ES96931100T ES2181908T3 ES 2181908 T3 ES2181908 T3 ES 2181908T3 ES 96931100 T ES96931100 T ES 96931100T ES 96931100 T ES96931100 T ES 96931100T ES 2181908 T3 ES2181908 T3 ES 2181908T3
Authority
ES
Spain
Prior art keywords
retinoid
compositions based
new compositions
vdr binding
synergetic mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96931100T
Other languages
English (en)
Inventor
Serge Michel
Veronique Dionisius-Pouget
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181908(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research and Development SNC, Centre International de Recherches Dermatologiques Galderma filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2181908T3 publication Critical patent/ES2181908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA ASOCIACION A BASE DE AL MENOS UN LIGANDO QUE PRESENTA UNA ACTIVIDAD SELECTIVA PARA EL RECEPTOR VDR Y DE UN RETINOIDE SELECTIVO DE LOS RECEPTORES RAR{SUB,GA} RESPECTO A LOS RECEPTORES RAR{SUB,AL}, LA UTILIZACION EN DERMATOLOGIA O EN COSMETOLOGIA DE ESTA ASOCIACION, DESTINADA A TRATAR LOS TRASTORNOS UNIDOS A UNA HIPERPROLIFERACION CELULAR, MAS EN PARTICULAR DE CELULAS DE LA PIEL, TALES COMO LA SORIASIS.
ES96931100T 1995-09-15 1996-09-10 Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide. Expired - Lifetime ES2181908T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations

Publications (1)

Publication Number Publication Date
ES2181908T3 true ES2181908T3 (es) 2003-03-01

Family

ID=9482603

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96931100T Expired - Lifetime ES2181908T3 (es) 1995-09-15 1996-09-10 Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.

Country Status (14)

Country Link
US (1) US6759396B1 (es)
EP (1) EP0788361B1 (es)
JP (1) JP2898100B2 (es)
AT (1) ATE218349T1 (es)
AU (1) AU687687B2 (es)
BR (1) BR9606648B1 (es)
CA (1) CA2204437C (es)
DE (1) DE69621580T2 (es)
DK (1) DK0788361T3 (es)
ES (1) ES2181908T3 (es)
FR (1) FR2738745B1 (es)
NZ (1) NZ318430A (es)
PT (1) PT788361E (es)
WO (1) WO1997009987A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
DE10255861A1 (de) * 2002-11-29 2004-06-17 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
US7750184B2 (en) * 2003-11-20 2010-07-06 Eli Lilly And Company Vitamin D receptor modulators
CA2544501A1 (en) * 2003-11-20 2005-06-09 Eli Lilly And Company Vitamin d receptor modulators
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
PL1771180T5 (pl) * 2004-06-17 2011-04-29 Galderma Sa Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową
BRPI0511389A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
WO2006133829A2 (de) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Verwendung von 25-hydroxy-vitamin d3
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法
RU2018119510A (ru) 2015-10-30 2019-12-05 Тимбер Фармасьютикалз ЭлЭлСи Композиции изотретиноина и их применение и способы

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713635B1 (fr) 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique

Also Published As

Publication number Publication date
MX9703461A (es) 1997-07-31
JP2898100B2 (ja) 1999-05-31
DE69621580T2 (de) 2003-03-13
US6759396B1 (en) 2004-07-06
FR2738745B1 (fr) 1997-10-24
FR2738745A1 (fr) 1997-03-21
ATE218349T1 (de) 2002-06-15
CA2204437C (fr) 2003-06-10
BR9606648A (pt) 1997-09-16
JPH10503533A (ja) 1998-03-31
EP0788361A1 (fr) 1997-08-13
EP0788361B1 (fr) 2002-06-05
AU687687B2 (en) 1998-02-26
DE69621580D1 (de) 2002-07-11
PT788361E (pt) 2002-11-29
CA2204437A1 (fr) 1997-03-20
BR9606648B1 (pt) 2009-01-13
AU6991296A (en) 1997-04-01
NZ318430A (en) 2000-09-29
WO1997009987A1 (fr) 1997-03-20
DK0788361T3 (da) 2002-07-15

Similar Documents

Publication Publication Date Title
ES2181908T3 (es) Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.
DE69720978D1 (de) Topische mittel, die eine öl-in-wasser emulsion und ein retinoid enthalten
BR9809465A (pt) Composições de cuidados com a pele e método para melhorar a aparência da pele
RU2003102634A (ru) Композиция для кондиционирования кожи, содержащие соединения, имитирующие действие ретиноевой кислоты на кожу
BR9407924A (pt) Corpo revestido processo para sua fabricaçao assim como emprego do mesmo
DE69617181T2 (de) Retinoid-Formulierungen in porösen Mikrokugeln für verringerte Irritation und verbesserte Stabilität
AR032287A1 (es) Una composicion cosmetica para el cuidado de la piel y metodos cosmeticos que utilizan dicha composicion
FI102142B (fi) Kosmeettinen koostumus, joka käsittää vähintään yhtä aktiivista ainett a sisältäviä, polymeerista tai rasvasta valmistettuja mikropalloja
FI953743A0 (fi) Keratolyyttistä ja/tai finnitaudinvastaista aktiivisuutta omaavia kosmeettisia koostumuksia, niiden valmistus ja käyttö
ES2175066T3 (es) Antagonistas triciclicos de la vasopresina.
KR880010751A (ko) 피부보호 조성물
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
DE68906992D1 (de) Indanylring enthaltende pyrethinester, deren herstellung und deren anwendung als pestizide.
Morelli et al. Contact dermatitis due to benzoyl peroxide.
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
FR2718640B1 (fr) Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations.
ES2152959T3 (es) Utilizacion en perfumeria de isomeros opticamente activos del (e)-3,3-dimetil-5-(2,2,3-trimetil-3-ciclopenten-1-il)-4-penten-2-ol.
DE69323191D1 (de) Wasserlösliche retinoide
DE69718168D1 (de) Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
DE59803222D1 (de) Kosmetische mittel
KR960020986A (ko) 두발화장품 조성물
KR890006806A (ko) 약쑥(애엽)분말이 함유된 피부보호 미용 비누 제조 방법
KR840003027A (ko) 마늘을 주성분으로 한 잔주름방지 화장품
RU94008830A (ru) Основа для косметических средств
TH28890A (th) องค์ประกอบของสารที่ใช้ดูแลรักษาผิวหนังที่มีกรดและเรตินอยด์อยู่